Added Value of a Neuroendocrine Test Battery in the Response to Repetitive Transcranial Magnetic Stimulation (rTMS) Trea
RecruitingNCT05964192Phase: NAStarted 2024-04-01
Summary
The primary objective of the study is to determine the predictive value of the neuroendocrine tests TRH-∆∆TSH (thyreoliberin - thyreostimulin) and DST (dexamethasone suppression test) in the subsequen
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Centre Hospitalier RouffachRouffach, Alsace, France
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05964192